Pahnke Jens, Wolkenhauer Olaf, Krohn Markus, Walker Lary C
University of Rostock, Department of Neurology, Neurodegeneration Research Laboratory (NRL), Gehlsheimer Str. 20, 18147 Rostock, Germany.
Curr Alzheimer Res. 2008 Aug;5(4):396-405. doi: 10.2174/156720508785132262.
In recent years it has become evident that ABC transporters fulfill important barrier functions in normal organs and during disease processes. Most importantly, resistance to drugs in cancer cells led to intense oncological and pharmacological investigations in which researchers were able to highlight important pharmacological interactions of chemotherapeuticals with ABC transporter function. Recently, the development of neurodegenerative diseases and the maintenance of neuronal stem cells have been linked to the activity of ABC transporters. Here, we summarize findings from cell culture experiments, animal models and studies of patients with Alzheimer's disease. Furthermore, we discuss pharmacological interactions and computational methods for risk assessment.
近年来,越来越明显的是,ABC转运蛋白在正常器官和疾病过程中发挥着重要的屏障功能。最重要的是,癌细胞对药物的耐药性引发了深入的肿瘤学和药理学研究,在此过程中,研究人员能够突出化疗药物与ABC转运蛋白功能之间重要的药理学相互作用。最近,神经退行性疾病的发展和神经干细胞的维持与ABC转运蛋白的活性有关。在这里,我们总结了细胞培养实验、动物模型以及阿尔茨海默病患者研究的结果。此外,我们还讨论了药理学相互作用和风险评估的计算方法。